Use of recombinant human activated protein C in patients with severe sepsis: a French retrospective multicentre study

By Muller Laurent   Jaber Samir   Raillard Alice   Lefrant Jean  

Intensive Care Medicine, Vol. 34, Iss. 5, 2008-05 ,pp. : 977-979

Springer Publishing Company

Access to resources Recommend Favorite

Recombinant Factor VII (Activated) for Haemorrhagic Complications of Severe Sepsis Treated with Recombinant Protein C (Activated)

By  

Acta Haematologica, Vol. 116, Iss. 2, 2006-08 ,pp. : 126-130

Karger

Access to resources Recommend Favorite

Septic shock caused by Streptococcus pneumoniae in a post-splenectomy patient successfully treated with recombinant human activated protein C

By Schumann Christian   Triantafilou Kathy   Kamenz Joachim   Hanke Hartmut   Triantafilou Martha   Wittemann Silke   Joos Thomas   Hombach Vinzenz   Schneider E. Marion   Lepper Philipp M.  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 2, 2006-02 ,pp. : 139-142

Informa Healthcare

Access to resources Recommend Favorite

Kinetics of Immune Parameters in a Patient with Sepsis Caused by Streptococcus pyogenes Treated with Activated Protein C

By Holub Michal   Helcl Miroslav   Beran Ondřej   Hnyková Jarmila   Příhodová Jana  

Scandinavian Journal of Infectious Diseases, Vol. 36, Iss. 6-7, 2004-07 ,pp. : 486-488

Informa Healthcare

Access to resources Recommend Favorite

Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta‐analysis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 4, 2015-04 ,pp. : 508-519

John Wiley & Sons Inc

Access to resources Recommend Favorite